News | April 05, 2011

Study Shows Gamma Knife Radiosurgery Spares More Healthy Tissue

April 5, 2011 – The volume of normal brain tissue exposed to radiation during treatment for multiple metastases appears to depend on which stereotactic radiosurgery system is employed, according to a recent study in the Journal of Neurosurgery.

Comparing treatment plans developed for use by three different treatment systems for a single patient (already previously treated with Leksell Gamma Knife), researchers found that Gamma Knife plans would result in "much smaller normal brain volumes receiving any particular dose" than the two other systems' plans.

The study compared treatment plans by Washington Fremont Hospital's (Fremont, Calif.) Leksell Gamma Knife Perfexion, the University of Utah's (Salt Lake City) BrainLAB Novalis system and the University of California San Francisco's Accuray CyberKnife system and involved a patient with 12 metastatic brain lesions.

"The discrepancy in normal brain volumes exposed between the Gamma Knife plans and those from CyberKnife and BrainLAB was generally on the order of two to three times lower for the Gamma Knife plans," says David Larson, M.D., Ph.D., radiation oncologist and co-medical director at Washington Fremont Hospital's Gamma Knife Program. "You could expect that patients and physicians would look more favorably on any radiation therapy treatment option that can demonstrate lower unintended radiation exposure to normal tissues."

This study is particularly compelling given trends in cancer survival and incidence. A major outcome of improved cancer therapies is that patients are living longer, which in turn may result in a higher incidence of patients experiencing recurrent brain metastases. Accordingly, for this growing population of cancer survivors, effective treatment of multiple brain metastases is increasingly essential.

For more information: www.elekta.com

Related Content

RayStation Selected for New Tennessee Proton Therapy Center
News | Treatment Planning | November 20, 2017
November 20, 2017 — Provision Healthcare has selected RayStation for external beam planning at the new Provision Care
Sponsored Content | Videos | Radiation Therapy | November 15, 2017
Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introd
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
ASTRO: CMS Report on Radiation Therapy Payment Model Charts Path to Value-Based Cancer Care
News | Radiation Therapy | November 08, 2017
The American Society for Radiation Oncology (ASTRO) called on the Centers for Medicare and Medicaid Services (CMS) to...
U.S. Recognizes Radiologic Technologists Nov. 5-11
News | Imaging | November 06, 2017
November 6, 2017 — During National Radiologic Technology Week (NRTW) every November, hospitals, healthcare centers an
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
PTCOG-NA Studies Address Cost and Coverage Issues With Proton Therapy
News | Proton Therapy | November 01, 2017
Physicians from across the country gathered in Chicago last week to discuss the most recent advances in proton therapy...
Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients
News | Proton Therapy | November 01, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Proton Therapy Shows Promising Clinical Benefits for Esophageal, Prostate and Breast Cancer
News | Proton Therapy | October 30, 2017
The National Association for Proton Therapy (NAPT) announced a number of clinical papers showing promising results were...
Overlay Init